SMART PRONIOSOMAL TRANSDERMAL PLATFORMS FOR CONTROLLED LOCAL ANESTHETIC DELIVERY OF LIDOCAINE

Localized pain control increasingly demands delivery systems that behave intelligently at the skin interface, delivering anesthetic precisely where needed while avoiding systemic spillover. Lidocaine, despite its clinical versatility, remains constrained by short duration of action and frequent reapplication when administered through conventional routes. Transdermal delivery offers an attractive alternative, yet the skin barrier and uncontrolled diffusion continue to limit therapeutic performance. Smart proniosomal transdermal platforms introduce a disruptive shift by coupling vesicular nanotechnology with skin-triggered self-assembly and controlled release behavior. Proniosomes are dry, storage-stable precursors that transform into niosomal vesicles upon hydration on the skin surface, generating a localized drug depot within the stratum corneum and viable epidermis. This review presents an integrative and forward-looking analysis of lidocaine-loaded proniosomal systems, focusing on formulation-driven control over vesicle architecture, interfacial dynamics, and anesthetic release profiles. The influence of surfactant chemistry, cholesterol content, and penetration enhancers on vesicle stability, drug entrapment, and dermal retention is critically examined. Advanced in vitro, ex vivo, and in vivo evaluation strategies are discussed to highlight prolonged anesthetic action, enhanced skin residency, and reduced systemic exposure. Beyond sustained delivery, proniosomal platforms enable modulation of spatial and temporal drug distribution, positioning them as precision-oriented systems rather than passive carriers. Emerging directions, including stimuli-responsive proniosomes, biointeractive excipients, and patient-adaptable designs, are highlighted as enablers of next-generation local anesthesia. Collectively, smart proniosomal transdermal systems redefine lidocaine delivery, offering a clinically compelling, scalable, and future-ready pathway for localized pain management in modern anesthetic and dermatological practice settings.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-04-30
DOI
https://doi.org/10.5281/zenodo.19912216
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SMART PRONIOSOMAL TRANSDERMAL PLATFORMS FOR CONTROLLED LOCAL ANESTHETIC DELIVERY OF LIDOCAINE

J. S. MALIK, Aditya Kumar, Vivek Gupta, Gyan Singh
Zenodo (CERN European Organization for Nuclear Research)
Advancements in Transdermal Drug Delivery
article

SMART PRONIOSOMAL TRANSDERMAL PLATFORMS FOR CONTROLLED LOCAL ANESTHETIC DELIVERY OF LIDOCAINE

J. S. MALIK, Aditya Kumar, Vivek Gupta, Gyan Singh
article en

Abstract

Localized pain control increasingly demands delivery systems that behave intelligently at the skin interface, delivering anesthetic precisely where needed while avoiding systemic spillover. Lidocaine, despite its clinical versatility, remains constrained by short duration of action and frequent reapplication when administered through conventional routes. Transdermal delivery offers an attractive alternative, yet the skin barrier and uncontrolled diffusion continue to limit therapeutic performance. Smart proniosomal transdermal platforms introduce a disruptive shift by coupling vesicular nanotechnology with skin-triggered self-assembly and controlled release behavior. Proniosomes are dry, storage-stable precursors that transform into niosomal vesicles upon hydration on the skin surface, generating a localized drug depot within the stratum corneum and viable epidermis. This review presents an integrative and forward-looking analysis of lidocaine-loaded proniosomal systems, focusing on formulation-driven control over vesicle architecture, interfacial dynamics, and anesthetic release profiles. The influence of surfactant chemistry, cholesterol content, and penetration enhancers on vesicle stability, drug entrapment, and dermal retention is critically examined. Advanced in vitro, ex vivo, and in vivo evaluation strategies are discussed to highlight prolonged anesthetic action, enhanced skin residency, and reduced systemic exposure. Beyond sustained delivery, proniosomal platforms enable modulation of spatial and temporal drug distribution, positioning them as precision-oriented systems rather than passive carriers. Emerging directions, including stimuli-responsive proniosomes, biointeractive excipients, and patient-adaptable designs, are highlighted as enablers of next-generation local anesthesia. Collectively, smart proniosomal transdermal systems redefine lidocaine delivery, offering a clinically compelling, scalable, and future-ready pathway for localized pain management in modern anesthetic and dermatological practice settings.

Zenodo (CERN European Organization for Nuclear Research)
RKDF University (IN)
Good health and well-being
Openalex Percentile: Top 7%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.